TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction

被引:95
作者
Hamada, S
Nishiue, T
Nakamura, S
Sugiura, T
Kamihata, H
Miyoshi, H
Imuro, Y
Iwasaka, T
机构
[1] Kansai Med Univ, Ctr Cardiovasc, Moriguchi, Osaka 5708507, Japan
[2] Kochi Med Sch, Dept Clin Lab Med, Kochi, Japan
关键词
D O I
10.1016/S0735-1097(01)01424-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The purpose of this study was to evaluate whether higher coronary blood flow, estimated by the corrected Thrombolysis In Myocardial Infarction (TIMI) frame count (CTFC), is related to better functional and clinical outcome after successful percutaneous transluminal coronary angioplasty (PTCA) in patients with acute myocardial infarction (AMI). BACKGROUND Experimental studies have found that functional recovery of the infarcted myocardium was associated with increased blood flow (reactive hyperemia) to the infarcted bed shortly after reperfusion. METHODS We measured CTFC immediately after successful (TIMI 3) primary PTCA in 104 consecutive patients with their first AMI. Wall motion score index (WMSI) and the presence of pericardial effusion were assessed by two-dimensional echocardiography before and one month after PTCA. RESULTS The patients were divided into two groups according to mean CTFC for corresponding coronary artery of the control group: TIMI 3 slow group (45 patients, 40 > CTFC greater than or equal to 23) and TIMI 3 fast group (59 patients, CTFC < 23). There were no significant differences in the baseline characteristics and WMSI before reperfusion between the two groups. Improvement of WMSI in the TIMI 3 fast group was significantly greater than that of the TIMI 3 slow group (1.33 +/- 0.52 vs. 0.60 +/- 0.34, p < 0.001). Pericardial effusion and intractable heart failure were observed more frequently in the TIMI 3 slow group than in the TIMI 3 fast group (27 vs. 10%; p < 0.05, 36 vs. 17%; p < 0.05). Corrected TIMI frame count, assessed as a continuous variable, had a significant correlation with the change in WMSI (r = 0.60, p < 0.001) after adjusting for age, gender, history of hypertension, history of diabetes, elapsed time to PTCA, collateral grade, presence of antegrade flow before PTCA and number of diseased vessels. CONCLUSIONS Lower CTFC of the infarct-related artery immediately after PTCA was associated with greater functional recovery; :and hence, CTFC can predict clinical and functional outcome in patients with successful PTCA. (C) 2001 by the American College of Cardiology.
引用
收藏
页码:666 / 671
页数:6
相关论文
共 34 条
[1]   Relation of phasic coronary flow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting [J].
Akasaka, T ;
Yoshida, K ;
Kawamoto, T ;
Kaji, S ;
Ueda, Y ;
Yamamuro, A ;
Takagi, T ;
Hozumi, T .
CIRCULATION, 2000, 101 (20) :2361-2367
[2]   TIMI PERFUSION GRADE-3 BUT NOT GRADE-2 RESULTS IN IMPROVED OUTCOME AFTER THROMBOLYSIS FOR MYOCARDIAL-INFARCTION - VENTRICULOGRAPHIC, ENZYMATIC, AND ELECTROCARDIOGRAPHIC EVIDENCE FROM THE TEAM-3 STUDY [J].
ANDERSON, JL ;
KARAGOUNIS, LA ;
BECKER, LC ;
SORENSEN, SG ;
MENLOVE, RL .
CIRCULATION, 1993, 87 (06) :1829-1839
[3]   ST-segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy [J].
Andrews, J ;
Straznicky, IT ;
French, JK ;
Green, CL ;
Maas, ACP ;
Lund, M ;
Krucoff, MW ;
White, HD .
CIRCULATION, 2000, 101 (18) :2138-2143
[4]   Corrected TIMI frame count does not predict 30-day adverse outcomes after reperfusion therapy for acute myocardial infarction [J].
Bhatt, DL ;
Ellis, SG ;
Ivanc, TB ;
Crowe, T ;
Balazs, E ;
Debowey, D ;
Pangerl, A ;
Chew, PH .
AMERICAN HEART JOURNAL, 1999, 138 (04) :785-790
[5]   THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE [J].
CHESEBRO, JH ;
KNATTERUD, G ;
ROBERTS, R ;
BORER, J ;
COHEN, LS ;
DALEN, J ;
DODGE, HT ;
FRANCIS, CK ;
HILLIS, D ;
LUDBROOK, P ;
MARKIS, JE ;
MUELLER, H ;
PASSAMANI, ER ;
POWERS, ER ;
RAO, AK ;
ROBERTSON, T ;
ROSS, A ;
RYAN, TJ ;
SOBEL, BE ;
WILLERSON, J ;
WILLIAMS, DO ;
ZARET, BL ;
BRAUNWALD, E .
CIRCULATION, 1987, 76 (01) :142-154
[6]   LOCAL EFFECTS OF ACUTE CELLULAR INJURY ON REGIONAL MYOCARDIAL BLOOD-FLOW [J].
COBB, FR ;
BACHE, RJ ;
RIVAS, F ;
GREENFIELD, JC .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (05) :1359-1368
[7]  
CRYSTAL GJ, 1988, AM J PHYSIOL, V254, P525
[8]   Impact of injection rate on the Thrombolysis In Myocardial Infarction (TIMI) trial frame count [J].
Dodge, JT ;
Rizzo, M ;
Nykiel, M ;
Altmann, J ;
Hobkirk, K ;
Brennan, M ;
Gibson, CM .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (10) :1268-+
[9]  
DROSSNER M, 1990, AM J PHYSIOL, V259, P603
[10]   Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial [J].
Gibson, CM ;
Goel, M ;
Cohen, DJ ;
Piana, RN ;
Deckelbaum, LI ;
Harris, KE ;
King, SB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (01) :28-34